The industry has been open, and in fact, suggesting these sorts of solutions from day one when this pandemic started. From it being, as I said earlier, a founding member of the accelerating access to COVID tools, the COVAX facility is part of that. It's very clear that they are negotiating, and it is a business. There are differential prices, as previous witnesses just mentioned, making sure that those prices are affordable for those countries that do not have the resources that some developed countries do.
There are a number of initiatives that industry has been very open to. There is no lack of understanding that this is a global pandemic and we need solutions. I can't speak to the individual arrangements for every company as that gets into commercial sensitivities, but we do know that some companies are offering at cost. They are not making a profit on this at all. There's a differing range and different models of approach to making sure that companies are able to be viable and continue the work they do, but also to make sure that every citizen of the globe is receiving their vaccination.